MACOM Technology Solutions Holdings, Inc. (MTSI) Stock Analysis and Metrics

MACOM Technology Solutions Holdings

NASDAQ: MTSI

$303.26 ▲ +9.02 (+3.07%)

At close: Jul 14, 2026 · 2:29 PM UTC

Financial Ratios

Market Cap26.40 Bn

P/E149.34

P/S24.58

Div. Yield0.00

ROIC (Qtr)0.00

Total Debt (Qtr)340.19 Mn

Revenue Growth (1y) (Qtr)22.50

Add ratio to table…

About

MACOM Technology Solutions Holdings, Inc. designs, develops, and manufactures high-performance semiconductor products and solutions for the Industrial and Defense (I&D), Data Center, and Telecommunications (Telecom) industries. The company specializes in analog and mixed-signal circuit design, compound semiconductor fabrication, advanced packaging, and back-end assembly and test. With over 70 years of application expertise, MACOM offers a broad portfolio of thousands of standard and custom devices, including integrated circuits (ICs), multi-chip modules (MCMs), diodes, amplifiers, switches, and radio frequency (RF) and optical subsystems. These products are integral components in larger electronic systems such as wireless base stations, high-capacity optical networks, data center networks, radar, medical systems, satellite networks, and test and measurement applications.

MACOM generates revenue through the sale of its high-performance RF, microwave, millimeter wave, optical, and photonic semiconductor products. The company sells these products to customers through a direct sales organization, a network of independent sales representatives, and distributors. Key drivers of revenue growth include the demand for high-performance analog, digital, and optical semiconductors, the introduction of new products with advanced technologies, increased content of semiconductor solutions in customers’ systems, and early engagement with lead customers for custom and standard product development.

The company operates through the following segments:

• Industrial and Defense (I&D): This segment serves applications such as military and commercial radar, RF jammers, electronic countermeasures, communication data links, space-related electronics, and various wired and wireless multi-market applications, including industrial, medical, test and measurement, and scientific applications.

• Data Center: This segment focuses on intra-Data Center and Data Center Interconnect (DCI) applications at speeds ranging from 100G to 3.2T and higher. It provides a broad portfolio of analog ICs and photonic components for high-speed connectivity customers.

• Telecommunications (Telecom): This segment includes carrier infrastructure such as long-haul/metro networks, 5G and 6G infrastructure, satellite communications (SATCOM), and Fiber-to-the-X (FTTx)/passive optical network (PON) solutions.

MACOM holds a strong position in the semiconductor industry, particularly in the markets it serves. The company's competitive advantages include its extensive application expertise, leadership in standard and catalog products, and ability to develop custom solutions tailored to customers' specific needs. MACOM's products are known for their high performance, quality, and reliability, which are critical in industries such as defense, data centers, and telecommunications. The company faces competition from other semiconductor manufacturers, but its focus on high-performance products and early engagement with customers helps it maintain a competitive edge.

The customer base of MACOM Technology Solutions Holdings, Inc. is diverse and spans multiple industries. The company serves over 6,000 end customers across its primary markets of I&D, Data Center, and Telecom. Specific customer names are not disclosed in the filing, but the types of customers include defense contractors, data center operators, telecommunications service providers, and manufacturers of electronic systems and equipment. The company's products are incorporated into larger electronic systems, indicating a broad range of end-users who rely on MACOM's components for their own products and solutions.

Investment Thesis

▲ Bull case

MACOM (MTSI) is positioned to capitalize on structural growth in the Data Center market beyond the current 1.6T optical transceiver cycle, with coherent light solutions emerging as a durable, high-margin opportunity that management has not fully quantified in guidance. While the company highlights 1.6T and 800G products as current growth drivers, CEO Daly noted coherent light’s potential to enable higher bandwidth with improved power efficiency in shorter-reach applications, a trend gaining traction among hyperscalers seeking to optimize AI cluster interconnects. This technology aligns with MACOM’s differentiated photodiode and laser portfolio, where internal development of 75-milliwatt class CW lasers is advancing toward reliability qualification, with commercial ramp potential in fiscal 2027 or 2028 not yet priced into near-term estimates. The omission of coherent light as a formal revenue contributor in current guidance suggests the market underestimates its long-term impact, especially as MACOM’s Ann Arbor fab achieves industry-leading dark current performance in stacked photodetector-TIA designs, a capability that could secure tier-one supplier status for next-generation optical modules. Given that data center capex remains robust and hyperscalers are diversifying beyond pluggable optics into co-packaged and near-packaged architectures, MACOM’s early investments in coherent light could unlock sustainable share gains in a segment where competitors lack comparable integrated photonic materials expertise.
The company’s Industrial and Defense (I&D) segment is benefiting from a multi-year domestic sourcing shift in U.S. and allied defense procurement that extends beyond temporary program timing, creating a structural tailwind MACOM is leveraging through its vertically integrated manufacturing footprint. While management cites current I&D growth above 20% and record revenues, it underemphasized how the DoD’s push for rapid system modernization—particularly in electronic warfare, drone defense, and space-based sensors—is increasing demand for high-frequency GaN and indium phosphide content per system, not just unit volume. MACOM’s Massachusetts fab investments in GaN and indium phosphide production, coupled with its North Carolina capacity expansion, position it to capture higher semiconductor content as defense systems migrate to millimeter-wave and optical technologies like RF-over-fiber. The recent GBP 45 million investment in IQE, which includes a long-term supply agreement for epitaxial materials, further de-risks exposure to indium phosphide and silicon carbide substrates—critical for both defense and optical products—yet this supply chain security initiative was framed as risk mitigation rather than a potential margin and volume enabler. With European defense spending rising in parallel with U.S. trends and MACOM noting parallel growth rates across regions, the I&D segment’s expansion is less cyclical and more reflective of a sustained reallocation of defense budgets toward advanced electronics, a dynamic not fully reflected in the low double-digit Telecom growth outlook.
MACOM’s capital allocation strategy is creating an underappreciated operating leverage inflection point, where disciplined CapEx of $55–65 million for fiscal 2026 (approximately 4–5% of revenue) is scaling capacity without proportional fixed-cost increases, enabling margin expansion that exceeds current expectations. Management highlighted incremental fab upgrades—such as the 30% wafer capacity increase in North Carolina achieved with minimal CapEx and the transition to 6-inch lines in France—yet did not connect these efficiency gains to the potential for operating leverage to accelerate as revenue scales. With adjusted operating income already at a record $80.5 million and operating margin improving to 27.8%, the company’s model shows that each incremental dollar of revenue is dropping through at a higher rate due to yieldexpansion, fab utilization gains from defense and optical product ramps, and stable depreciation. The CFO’s comment that operating margin could reach ~30% next quarter, combined with a persistent 3% tax rate supported by deferred tax assets, suggests EPS growth could outpace revenue growth more substantially than current guidance implies. This leverage is particularly potent given the record 1.5:1 book-to-bill ratio, which reflects near-term conversion potential (18% of revenue booked and shipped within the quarter) and provides visibility into sustained sequential growth without requiring new factory investments, a constraint management explicitly acknowledged.

MACOM (MTSI) is positioned to capitalize on structural growth in the Data Center market beyond the current 1.6T optical transceiver cycle, with coherent light solutions emerging as a durable, high-margin opportunity that management has not fully quantified in guidance. While the company highlights 1.6T and 800G products as current growth drivers, CEO Daly noted coherent light’s potential to enable higher bandwidth with improved power efficiency in shorter-reach applications, a trend gaining traction among hyperscalers seeking to optimize AI cluster interconnects. This technology aligns with MACOM’s differentiated photodiode and laser portfolio, where internal development of 75-milliwatt class CW lasers is advancing toward reliability qualification, with commercial ramp potential in fiscal 2027 or 2028 not yet priced into near-term estimates. The omission of coherent light as a formal revenue contributor in current guidance suggests the market underestimates its long-term impact, especially as MACOM’s Ann Arbor fab achieves industry-leading dark current performance in stacked photodetector-TIA designs, a capability that could secure tier-one supplier status for next-generation optical modules. Given that data center capex remains robust and hyperscalers are diversifying beyond pluggable optics into co-packaged and near-packaged architectures, MACOM’s early investments in coherent light could unlock sustainable share gains in a segment where competitors lack comparable integrated photonic materials expertise.
The company’s Industrial and Defense (I&D) segment is benefiting from a multi-year domestic sourcing shift in U.S. and allied defense procurement that extends beyond temporary program timing, creating a structural tailwind MACOM is leveraging through its vertically integrated manufacturing footprint. While management cites current I&D growth above 20% and record revenues, it underemphasized how the DoD’s push for rapid system modernization—particularly in electronic warfare, drone defense, and space-based sensors—is increasing demand for high-frequency GaN and indium phosphide content per system, not just unit volume. MACOM’s Massachusetts fab investments in GaN and indium phosphide production, coupled with its North Carolina capacity expansion, position it to capture higher semiconductor content as defense systems migrate to millimeter-wave and optical technologies like RF-over-fiber. The recent GBP 45 million investment in IQE, which includes a long-term supply agreement for epitaxial materials, further de-risks exposure to indium phosphide and silicon carbide substrates—critical for both defense and optical products—yet this supply chain security initiative was framed as risk mitigation rather than a potential margin and volume enabler. With European defense spending rising in parallel with U.S. trends and MACOM noting parallel growth rates across regions, the I&D segment’s expansion is less cyclical and more reflective of a sustained reallocation of defense budgets toward advanced electronics, a dynamic not fully reflected in the low double-digit Telecom growth outlook.
MACOM’s capital allocation strategy is creating an underappreciated operating leverage inflection point, where disciplined CapEx of $55–65 million for fiscal 2026 (approximately 4–5% of revenue) is scaling capacity without proportional fixed-cost increases, enabling margin expansion that exceeds current expectations. Management highlighted incremental fab upgrades—such as the 30% wafer capacity increase in North Carolina achieved with minimal CapEx and the transition to 6-inch lines in France—yet did not connect these efficiency gains to the potential for operating leverage to accelerate as revenue scales. With adjusted operating income already at a record $80.5 million and operating margin improving to 27.8%, the company’s model shows that each incremental dollar of revenue is dropping through at a higher rate due to yieldexpansion, fab utilization gains from defense and optical product ramps, and stable depreciation. The CFO’s comment that operating margin could reach ~30% next quarter, combined with a persistent 3% tax rate supported by deferred tax assets, suggests EPS growth could outpace revenue growth more substantially than current guidance implies. This leverage is particularly potent given the record 1.5:1 book-to-bill ratio, which reflects near-term conversion potential (18% of revenue booked and shipped within the quarter) and provides visibility into sustained sequential growth without requiring new factory investments, a constraint management explicitly acknowledged.

▼ Bear case

MACOM (MTSI) faces significant margin compression risk from unaddressed pricing pressure in the Data Center optical component market, where hyperscalers’ increasing vertically integrated designs and co-packaged optics (CPO) adoption could commoditize MACOM’s current product strengths despite management’s optimism about portfolio diversification. While the company highlights growth in 1.6T and 800G PAM4 products and coherent light as future opportunities, it did not adequately address how hyperscalers like Google, Meta, and Amazon are developing in-house optical engines or pursuing CPO/NPO architectures that reduce reliance on discrete semiconductor suppliers for key functions such as lasers and photodetectors. CEO Daly acknowledged coherent light’s dependence on hyperscaler deployment decisions but did not quantify the risk that if these players internalize more of the optical subsystem—particularly through silicon photonics integration—the addressable market for MACOM’s discrete photodiodes, TIAs, and DFB lasers could shrink faster than new coherent light opportunities emerge. This is especially concerning given that the company’s gross margin improvement of 90 basis points sequentially was partially attributed to Data Center revenue mix, yet management conceded that in some instances, this segment’s growth does not contribute to margin expansion, hinting at underlying pricing or mix dilution that could worsen as scale increases. The lack of discussion around competitive pricing dynamics or long-term supply contracts with hyperscalers suggests the market may be ignoring the durability of MACOM’s current Data Center advantage.
The Telecom segment’s anticipated recovery tied to LEO satellite programs is highly dependent on uncertain program timelines and customer-specific design cycles, creating substantial execution risk that management downplayed by characterizing the ramp as a gradual “ramp-up” rather than acknowledging potential delays or cancellations in a capital-intensive, low-margin market. While CEO Daly confirmed active LEO production programs and LRIP-phase projects, he noted that larger programs like the EM module initiative are still in the system design finalization phase, with full-rate production not expected until late 2026 or early 2027—yet he framed this as consistent with prior guidance without addressing the risk of further slippage given the complexity of satellite integration and the historical volatility of LEO constellation funding. The Telecom segment’s low single-digit sequential growth in Q2, despite management’s optimism about “low double-digit” growth for the year, reveals a disconnect between expectation and current performance, particularly as the company admitted it is only opportunistically pursuing user terminal markets and not chasing highly integrated SoCs. This reliance on external program timelines, combined with MACOM’s lack of disclosure about customer concentration or backlog visibility in Telecom, leaves the segment vulnerable to shifts in satellite operator capital expenditure plans, especially if macroeconomic pressures or launch delays affect constellations like Starlink, Kuiper, or OneWeb. The market may be ignoring how Telecom’s recovery is not a self-driven product cycle but a derivative of third-party satellite deployment schedules, which are inherently lumpy and unpredictable.
MACOM’s aggressive R&D investment of $59.1 million in Q2—representing over 66% of adjusted operating expenses—is creating a hidden drag on near-term profitability that could undermine operating leverage if new product ramps fail to translate into timely revenue, despite management’s framing of these expenditures as strategic investments for future growth. While the company highlights progress in GaN 4 for 5G base stations, new IPD processes, and indium phosphide development, it did not provide sufficient evidence that these projects are on track to deliver volume production within the fiscal 2026 or 2027 windows, particularly given CEO Daly’s admission that CW laser qualification could slip into fiscal 2028 even under optimistic scenarios. The R&D spend, which increased alongside hiring and scaling efforts, is not being offset by commensurate revenue from commercialized technologies, raising the risk that the company is over-investing in next-generation products while under-monetizing its current portfolio. This imbalance is exacerbated by the CFO’s note that operating expense growth will be primarily driven by R&D and variable costs as the business expands, suggesting that without a clear path to revenue conversion, the elevated R&D intensity could pressure operating margins. The market may be ignoring how the company’s current 27.8% operating margin relies heavily on temporary gross margin improvements from volume and yield gains, which could reverse if R&D fails to produce commercially viable, high-margin products in a timely fashion, turning innovation into a persistent cost center rather than a growth engine.

MACOM (MTSI) faces significant margin compression risk from unaddressed pricing pressure in the Data Center optical component market, where hyperscalers’ increasing vertically integrated designs and co-packaged optics (CPO) adoption could commoditize MACOM’s current product strengths despite management’s optimism about portfolio diversification. While the company highlights growth in 1.6T and 800G PAM4 products and coherent light as future opportunities, it did not adequately address how hyperscalers like Google, Meta, and Amazon are developing in-house optical engines or pursuing CPO/NPO architectures that reduce reliance on discrete semiconductor suppliers for key functions such as lasers and photodetectors. CEO Daly acknowledged coherent light’s dependence on hyperscaler deployment decisions but did not quantify the risk that if these players internalize more of the optical subsystem—particularly through silicon photonics integration—the addressable market for MACOM’s discrete photodiodes, TIAs, and DFB lasers could shrink faster than new coherent light opportunities emerge. This is especially concerning given that the company’s gross margin improvement of 90 basis points sequentially was partially attributed to Data Center revenue mix, yet management conceded that in some instances, this segment’s growth does not contribute to margin expansion, hinting at underlying pricing or mix dilution that could worsen as scale increases. The lack of discussion around competitive pricing dynamics or long-term supply contracts with hyperscalers suggests the market may be ignoring the durability of MACOM’s current Data Center advantage.
The Telecom segment’s anticipated recovery tied to LEO satellite programs is highly dependent on uncertain program timelines and customer-specific design cycles, creating substantial execution risk that management downplayed by characterizing the ramp as a gradual “ramp-up” rather than acknowledging potential delays or cancellations in a capital-intensive, low-margin market. While CEO Daly confirmed active LEO production programs and LRIP-phase projects, he noted that larger programs like the EM module initiative are still in the system design finalization phase, with full-rate production not expected until late 2026 or early 2027—yet he framed this as consistent with prior guidance without addressing the risk of further slippage given the complexity of satellite integration and the historical volatility of LEO constellation funding. The Telecom segment’s low single-digit sequential growth in Q2, despite management’s optimism about “low double-digit” growth for the year, reveals a disconnect between expectation and current performance, particularly as the company admitted it is only opportunistically pursuing user terminal markets and not chasing highly integrated SoCs. This reliance on external program timelines, combined with MACOM’s lack of disclosure about customer concentration or backlog visibility in Telecom, leaves the segment vulnerable to shifts in satellite operator capital expenditure plans, especially if macroeconomic pressures or launch delays affect constellations like Starlink, Kuiper, or OneWeb. The market may be ignoring how Telecom’s recovery is not a self-driven product cycle but a derivative of third-party satellite deployment schedules, which are inherently lumpy and unpredictable.
MACOM’s aggressive R&D investment of $59.1 million in Q2—representing over 66% of adjusted operating expenses—is creating a hidden drag on near-term profitability that could undermine operating leverage if new product ramps fail to translate into timely revenue, despite management’s framing of these expenditures as strategic investments for future growth. While the company highlights progress in GaN 4 for 5G base stations, new IPD processes, and indium phosphide development, it did not provide sufficient evidence that these projects are on track to deliver volume production within the fiscal 2026 or 2027 windows, particularly given CEO Daly’s admission that CW laser qualification could slip into fiscal 2028 even under optimistic scenarios. The R&D spend, which increased alongside hiring and scaling efforts, is not being offset by commensurate revenue from commercialized technologies, raising the risk that the company is over-investing in next-generation products while under-monetizing its current portfolio. This imbalance is exacerbated by the CFO’s note that operating expense growth will be primarily driven by R&D and variable costs as the business expands, suggesting that without a clear path to revenue conversion, the elevated R&D intensity could pressure operating margins. The market may be ignoring how the company’s current 27.8% operating margin relies heavily on temporary gross margin improvements from volume and yield gains, which could reverse if R&D fails to produce commercially viable, high-margin products in a timely fashion, turning innovation into a persistent cost center rather than a growth engine.

End Market Breakdown of Revenue (2025)

Peer Comparison

Companies in the Semiconductors

S.No.	Ticker	Company	Market Cap	P/E	P/S	Total Debt (Qtr)
1	NVDA	Nvidia Corp	4,798.43 Bn	0.00 Bn	18.93	8.47 Bn
2	MU	Micron Technology Inc	1,164.41 Bn	0.00 Bn	12.90	5.72 Bn
3	AMD	Advanced Micro Devices Inc	882.18 Bn	0.00 Bn	23.55	3.22 Bn
4	INTC	Intel Corp	645.64 Bn	0.00 Bn	12.01	45.03 Bn
5	ALMU	Aeluma, Inc.	370.26 Bn	0.00 Bn	71,258.42	-
6	ARM	Arm Holdings Plc /Uk	358.73 Bn	427.06 Bn	72.91	-
7	TXN	Texas Instruments Inc	271.25 Bn	0.00 Bn	14.71	14.05 Bn
8	MRVL	Marvell Technology, Inc.	239.95 Bn	0.00 Bn	27.53	4.96 Bn

Research Tools

Developers

About

Investment Thesis

Geographical Breakdown of Revenue (2025)

End Market Breakdown of Revenue (2025)

Peer Comparison

Research Tools

Developers

About

Investment Thesis

Geographical Breakdown of Revenue (2025)

End Market Breakdown of Revenue (2025)

Peer Comparison

Create an account

Sign In

Reset Password